Literature DB >> 2688562

A simple method for elution of IgA deposits from the skin of patients with dermatitis herpetiformis.

P Jones1, V Kumar, E H Beutner, T P Chorzelski.   

Abstract

To better understand the role of autoimmunity in the pathogenesis of dermatitis herpetiformis, linear IgA bullous dermatosis or other skin disorders, the antigenic specificity of the immune reactants bound in vivo in the skin must be identified. In order to do so, one must first be able to elute these immune reactants from the skin. We describe here a simple method of eluting not only specifically bound IgG, but also IgA and other immunoglobulins and complement components from skin biopsy material. The method involves cutaneous washing of the entrapped serum proteins in PBS pH 7 and pH 5 buffers followed by specific immunoglobulin elutions at pH 3 and 2. The IgA deposits which could not be removed by this treatment were eluted by a combination of low pH (0.5 M citrate pH 2) and a chaotropic agent (2 M NaCl). The relative concentration of IgA in eluates when quantitated by fluoroimmunoassay were three- to five-fold higher in dermatitis herpetiformis skin biopsy specimens, than in eluates of bullous pemphigoid or normal skin biopsy specimens.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2688562     DOI: 10.1007/bf00455326

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  15 in total

Review 1.  The pathogenesis of dermatitis herpetiformis.

Authors:  S I Katz; W Strober
Journal:  J Invest Dermatol       Date:  1978-02       Impact factor: 8.551

2.  Dermatitis herpetiformis: extraction of intact IgA from granular deposits in dermal papillae.

Authors:  L J Meyer; L Carioto; J J Zone
Journal:  J Invest Dermatol       Date:  1987-05       Impact factor: 8.551

3.  Identification of IgA binding structures in skin of patients with dermatitis herpetiformis.

Authors:  H Yaoita
Journal:  J Invest Dermatol       Date:  1978-09       Impact factor: 8.551

4.  Gluten challenge in dermatitis herpetiformis.

Authors:  J Leonard; G Haffenden; W Tucker; J Unsworth; F Swain; R McMinn; J Holborow; L Fry
Journal:  N Engl J Med       Date:  1983-04-07       Impact factor: 91.245

5.  Immunofluorescence studies in psoriasis: detection of antibodies to stratum corneum in psoriatic scales.

Authors:  V Kumar; P Jones; E H Beutner; S Jablonska
Journal:  Ann N Y Acad Sci       Date:  1983       Impact factor: 5.691

6.  IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease.

Authors:  T P Chorzelski; E H Beutner; J Sulej; H Tchorzewska; S Jablonska; V Kumar; A Kapuscinska
Journal:  Br J Dermatol       Date:  1984-10       Impact factor: 9.302

7.  Dermatitis herpetiformis: the skin and the gut.

Authors:  S I Katz; R P Hall; T J Lawley; W Strober
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391

Review 8.  The pathogenesis of dermatitis herpetiformis: recent advances.

Authors:  R P Hall
Journal:  J Am Acad Dermatol       Date:  1987-06       Impact factor: 11.527

9.  Dermatitis herpetiformis: biochemical properties of the granular deposits of IgA in papillary dermis. Characterization of SDS-soluble IgA-like material and potentially antigen-binding IgA fragments released by pepsin.

Authors:  T Egelrud; O Bäck
Journal:  J Invest Dermatol       Date:  1985-04       Impact factor: 8.551

10.  Dermatitis herpetiformis: preparation of papillary dermis and the effect of proteolytic enzymes on the IgA deposits.

Authors:  T Egelrud; O Bäck
Journal:  J Invest Dermatol       Date:  1984-05       Impact factor: 8.551

View more
  1 in total

1.  Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target.

Authors:  Florencia Palacios; Xiao-Jie Yan; Gerardo Ferrer; Shih-Shih Chen; Stefano Vergani; Xuejing Yang; Jeffrey Gardner; Jaqueline C Barrientos; Philip Rock; Richard Burack; Jonathan E Kolitz; Steven L Allen; Michael G Kharas; Omar Abdel-Wahab; Kanti R Rai; Nicholas Chiorazzi
Journal:  Leukemia       Date:  2021-01-27       Impact factor: 11.528

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.